(Q33481705)

27 July 2017

Identification of IMPDH2 as a tumor-associated antigen in colorectal cancer using immunoproteomics analysis (English)

1 reference

27 July 2017

1 reference

1 reference

Tao Fu

5

0 references

author name string

Yujun He

1

1 reference

27 July 2017

Zhirong Mou

2

1 reference

27 July 2017

Wanlin Li

3

1 reference

27 July 2017

Baohua Liu

4

1 reference

27 July 2017

Shong Zhao

6

1 reference

27 July 2017

Debing Xiang

7

1 reference

27 July 2017

Yuzhang Wu

8

1 reference

27 July 2017

14 July 2009

1 reference

International Journal of Colorectal Disease

27 July 2017

1 reference

27 July 2017

24

1 reference

27 July 2017

1271-1279

1 reference

27 July 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1007/s00384-009-0759-2

27 July 2017

0 references

cites work

Proteomics approaches to identify tumor antigen directed autoantibodies as cancer biomarkers

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00384-009-0759-2

Identification of metabolic enzymes in renal cell carcinoma utilizing PROTEOMEX analyses

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00384-009-0759-2

Identification of tumor antigens in renal cell carcinoma by serological proteome analysis

21 January 2018

1 reference

12 December 2020

Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer.

1 reference

12 December 2020

In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis

1 reference

12 December 2020

Clinico-pathological characteristics of colorectal cancer and serum anti-p53 antibodies

1 reference

12 December 2020

Benzamide riboside induced mitochondrial mediated apoptosis in human lung cancer H520 cells

1 reference

12 December 2020

An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer

1 reference

12 December 2020

Molecular targets of guanine nucleotides in differentiation, proliferation and apoptosis

1 reference

12 December 2020

Monitoring of inosine monophosphate dehydrogenase activity in mononuclear cells of children with acute lymphoblastic leukemia: enzymological and clinical aspects

1 reference

12 December 2020

Design of proteome-based studies in combination with serology for the identification of biomarkers and novel targets

1 reference

12 December 2020

Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma

1 reference

12 December 2020

Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinoma

1 reference

12 December 2020

Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients

1 reference

12 December 2020

Tissue-differential expression of two distinct genes for human IMP dehydrogenase (E.C.1.1.1.205).

1 reference

12 December 2020

Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer

1 reference

12 December 2020

Recent development of IMP dehydrogenase inhibitors for the treatment of cancer.

1 reference

12 December 2020

1 reference

12 December 2020

Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer

1 reference

12 December 2020

Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinoma

1 reference

12 December 2020

Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma

1 reference

12 December 2020

A proteomic primer for the clinician

1 reference

12 December 2020

Increased inosine-5'-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines

1 reference

12 December 2020

Induction by the guanosine analogue oxanosine of reversion toward the normal phenotype of K-ras-transformed rat kidney cells.

1 reference

12 December 2020

Inosine monophosphate dehydrogenase expression: transcriptional regulation of the type I and type II genes

1 reference

12 December 2020

IMP dehydrogenase, an enzyme linked with proliferation and malignancy

1 reference

12 December 2020

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

1 reference

12 December 2020

Cancer statistics, 2008

1 reference

12 December 2020

Tissue expression and sero-reactivity of tumor-specific antigens in colorectal cancer.

1 reference

12 December 2020

Strategies for plasma proteomic profiling of cancers

1 reference

12 December 2020

Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding

1 reference

12 December 2020

CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma

1 reference

12 December 2020

A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis

1 reference

12 December 2020

Allogenic antibody-mediated identification of head and neck cancer antigens

1 reference

12 December 2020

Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway

1 reference

12 December 2020

An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer

1 reference

12 December 2020

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

1 reference

12 December 2020

Asia Pacific consensus recommendations for colorectal cancer screening.

1 reference

12 December 2020

Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cells

1 reference

12 December 2020

10.1007/S00384-009-0759-2

Identifiers

DOI

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference